Group 1 - The core viewpoint of the news is that the CSI Hong Kong 300 Biopharmaceutical Index has shown significant growth, with a 24.33% increase over the past month, a 60.33% increase over the past three months, and a remarkable 137.42% increase year-to-date [1] - The CSI Hong Kong 300 Industry Index series is categorized according to the China Securities Index industry classification standards, reflecting the overall performance of different industries in the Hong Kong market [1] - The CSI Hong Kong 300 Biopharmaceutical Index is composed entirely of securities from the Hong Kong Stock Exchange, with 100% of its holdings in the biopharmaceutical sector [1] Group 2 - The index sample is adjusted every six months, with adjustments implemented on the next trading day following the second Friday of June and December each year [2] - Weight factors are generally fixed until the next scheduled adjustment, but can be modified in the event of temporary adjustments due to changes in the underlying index samples [2] - Special events affecting sample companies, such as delisting or mergers, will lead to corresponding adjustments in the CSI Hong Kong 300 Industry Index series [2]

Core Insights - The CSI Hong Kong 300 Biopharmaceutical Index (H300 Biopharmaceuticals) reported a value of 958.77 points, showing a significant upward trend [1] - The index has increased by 2.89% over the past month, 34.24% over the past three months, and 47.43% year-to-date [1] - The index is designed to reflect the overall performance of different industries in the Hong Kong market, based on the CSI industry classification standards [1] Index Composition - The CSI Hong Kong 300 Biopharmaceutical Index consists entirely of securities listed on the Hong Kong Stock Exchange, with a 100% allocation [1] - The index is composed solely of the biopharmaceutical sector, indicating a focused investment strategy [1] Index Adjustment Mechanism - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with temporary adjustments made in response to significant events affecting sample companies [2] - Events such as delisting, mergers, or changes in industry classification will prompt corresponding adjustments to the index samples [2]